1 Department of Palliative Care, Policy & Rehabilitation, Cicely Saunders Institute, King's College London, London, UK.
2 Bristol Randomised Trials Collaboration (BRTC), School of Social and Community Medicine, Faculty of Health Sciences, University of Bristol, Bristol, UK.
Palliat Med. 2018 Sep;32(8):1288-1304. doi: 10.1177/0269216318783919. Epub 2018 Jun 29.
Patient empowerment, defined as 'a process through which people gain greater control over decisions and actions affecting their health' (World Health Organization) is a key theme within global health and social care strategies. The benefits of incorporating empowerment strategies in care are well documented, but little is known about their application or impact for patients with advanced, life-limiting illness(s).
To identify and synthesise the international evidence on patient empowerment for adults with advanced, life-limiting illness(s).
Systematic review (PROSPERO no. 46113) with critical interpretive synthesis methodology.
Five databases (MEDLINE, Embase, CINHAL, PsycINFO and Cochrane) were searched from inception to March 2018. Grey literature and reference list/citation searches of included papers were undertaken.
empirical research involving patients with advanced life-limiting illness including descriptions of, or references to, patient empowerment within the study results.
In all, 13 papers met inclusion criteria. Two qualitative studies explored patient empowerment as a study objective. Six papers evaluated interventions, referencing patient empowerment as an incidental outcome. The following themes were identified from the interpretive synthesis: self-identity, personalised knowledge in theory and practice, negotiating personal and healthcare relationships, acknowledgement of terminal illness, and navigating continued losses.
There are features of empowerment, for patients with advanced life-limiting illness distinct to those of other patient groups. Greater efforts should be made to progress the empowerment of patients nearing the end of their lives. We propose that the identified themes may provide a useful starting point to guide the assessment of existing or planned services and inform future research.
患者赋权,定义为“一个使人们在影响其健康的决策和行动中获得更大控制权的过程”(世界卫生组织),是全球卫生和社会保健战略中的一个关键主题。在护理中纳入赋权策略的益处已有充分记录,但对于患有晚期、生命有限疾病的患者,对其应用或影响知之甚少。
确定并综合国际上关于晚期、生命有限疾病患者赋权的证据。
系统评价(PROSPERO 编号 46113),结合关键解释性综合方法。
从开始到 2018 年 3 月,对五个数据库(MEDLINE、Embase、CINHAL、PsycINFO 和 Cochrane)进行了搜索。对纳入文献的灰色文献和参考文献/引文进行了搜索。
涉及晚期生命有限疾病患者的实证研究,包括研究结果中对患者赋权的描述或提及。
共有 13 篇论文符合纳入标准。两项定性研究将患者赋权作为研究目标进行了探索。六篇论文评估了干预措施,将患者赋权作为偶然结果提及。从解释性综合中确定了以下主题:自我认同、理论和实践中的个性化知识、协商个人和医疗保健关系、承认终末期疾病、以及应对持续的损失。
对于患有晚期生命有限疾病的患者,赋权的特征与其他患者群体的特征不同。应该更加努力地推进接近生命尽头的患者的赋权。我们提出,所确定的主题可能为评估现有或计划中的服务以及为未来的研究提供有用的起点提供了指导。